Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hayes

Showing results (31-40 of 336) with videos related to

Pageof 34
Sort By:
Current Treatment Options in Oncology|June 12, 2002
Approach to menopausal symptoms in women with breast cancerVered Stearns, Daniel F Hayes
Journal of the National Cancer Institute|June 11, 2009
Re: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cellsDaniel F Hayes, Massimo Cristofanilli
Annual Review of Medicine|January 16, 2014
Molecular testing in breast cancerCostanza Paoletti, Daniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Cooling off hot flashesVered Stearns, Daniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2004
Adjuvant chemotherapy for elderly women with hormone receptor-positive breast cancer: an old(er) problemAnne Schott, Daniel F Hayes
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Is there a role for circulating tumor cells in the management of breast cancer?Daniel F Hayes, Jeffrey Smerage
Nature Reviews. Clinical Oncology|November 22, 2017
Disseminated breast tumour cells: biological and clinical meaningKlaus Pantel, Daniel F Hayes
Advances in Experimental Medicine and Biology|March 19, 2016
Circulating Tumor CellsCostanza Paoletti, Daniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Circulating tumor cells: not all detected cells are bad and not all bad cells are detectedMax S Wicha, Daniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2006
Heart of darkness: the downside of trastuzumabDaniel F Hayes, Michael H Picard
Pageof 34

Showing results (31-40 of 336) with videos related to

Sort By:
Pageof 34
Current Treatment Options in Oncology|June 12, 2002
Approach to menopausal symptoms in women with breast cancerVered Stearns, Daniel F Hayes
Journal of the National Cancer Institute|June 11, 2009
Re: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cellsDaniel F Hayes, Massimo Cristofanilli
Annual Review of Medicine|January 16, 2014
Molecular testing in breast cancerCostanza Paoletti, Daniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Cooling off hot flashesVered Stearns, Daniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2004
Adjuvant chemotherapy for elderly women with hormone receptor-positive breast cancer: an old(er) problemAnne Schott, Daniel F Hayes
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Is there a role for circulating tumor cells in the management of breast cancer?Daniel F Hayes, Jeffrey Smerage
Nature Reviews. Clinical Oncology|November 22, 2017
Disseminated breast tumour cells: biological and clinical meaningKlaus Pantel, Daniel F Hayes
Advances in Experimental Medicine and Biology|March 19, 2016
Circulating Tumor CellsCostanza Paoletti, Daniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Circulating tumor cells: not all detected cells are bad and not all bad cells are detectedMax S Wicha, Daniel F Hayes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2006
Heart of darkness: the downside of trastuzumabDaniel F Hayes, Michael H Picard
Pageof 34